ACCCBUZZ BLOG

This May, ACCC is recognizing Bladder Cancer Awareness Month with a message highlighting the importance of awareness, patient education, and support.

In recognition of May as skin cancer awareness month, a disease that affects one in five Americans by 70 years of age, ACCC has developed new resources to support advanced skin cancer care.

ACCCBuzz spoke with Dr. Gabriela Hobbs, MD, at Massachusetts General Hospital Cancer Center to learn how to best manage patients' care for those with myelofibrosis.

ACCC held a LinkedIn live event on March 13, 2023, with subject matter experts, who shared strategies for tackling lung cancer disparities in the Appalachian Region and beyond.

March is Multiple Myeloma Awareness Month. Learn more about the work ACCC is doing to support oncology professionals in treating patients with this disease.

In recognition of National Cancer Prevention Month, the continued effort toward preventing cancer must be characterized by actions not words.

ACCCBuzz spoke with Dr. Jessica Unzaga at Baptist Health’s Miami Cancer Institute, to help consider the use of triplet vs. quadruplet regimens in the treatment of multiple myeloma.

Every November we remember National Lung Cancer Awareness Month. So ACCCBuzz spoke with Caroline Wolf to learn more about CHI Memorial's lung screening outreach efforts and Breathe Easy Mobile Lung Screening Program.

ACCC has engaged experts through a vodcast series from CANCER BUZZ TV, focusing on specific issues regarding treatment adherence to oral therapies, treatment-related side effects, patient education, and financial barriers for patients with HR+, HER2- breast cancer.

In recognition of the13th annual Metastatic Breast Cancer Awareness Day, read one patient's inspiring journey, a story punctuated by incredible bravery and indomitable hope.

ACCCBuzz spoke with Dr. Dan Vogl to learn more about the treatment options available to patients with multiple myeloma, including the benefits of adding anti-CD38 monoclonal antibodies in either first- or second-line treatment.

Care optimization is everything in today’s rapidly changing healthcare landscape. Learn how ACCC's nationwide quality improvement (QI) initiative helped Southern Ohio Medical Center Cancer Center develop and implement plans to support the optimization of care for patients diagnosed with Stages III and IV non-small cell lung cancer (NSCLC).

The COVID-19 pandemic had a significant impact on the cancer screening rate. While telemedicine has facilitated care delivery, there is a need for programs aimed at promoting screening. This understanding prompted Mercy Medical Center-Cedar Rapids, Hall-Perrine Cancer Center in Iowa to launch a initiative that has excelled in increasing their colorectal screening rates, and facilitated the provision of high-quality care in the community.

Communities around the globe recognize August 1 as World Lung Cancer Day—a day to commemorate, educate, and support individuals and families impacted by lung cancer. Read highlights on a few ACCC initiatives that are helping cancer care teams better support their patients with this disease.

The US has seen a steady decline in the overall incidence of colorectal cancer (CRC) during the past several decades. In 1975, 60 people per 100,000 were diagnosed with colorectal cancer; by 2018, that number had fallen to 34. But overall trends in CRC incidence and outcomes often differ among racial groups and geographic locations. Black Americans are more likely to be diagnosed with CRC than White Americans and more likely to die from it. CRC mortality rates in American Indian and Alaska Native populations have stubbornly stayed put.

In 2020, medical experts warned that COVID-19 could, over time, have a substantial impact on cancer outcomes due to delayed or missed cancer screenings for patients. To obtain a better perspective of how cancer programs’ screening and outreach education efforts are recovering from pandemic pressures, ACCCBuzz spoke to four cancer programs across the country.

Lung cancer is the leading cause of cancer death and the second-most common cancer detected in both men and women in the U.S. Lung cancer accounts for nearly 25% of all cancer deaths in this country. According to estimates by the American Cancer Society, 235,760 patients will be diagnosed with lung cancer, and 131,880 patients will die of the disease in 2021.

In launching its new campaign, Transforming Complex To Clear, ACCC brought together expert panelists to discuss effective practices and offer tips to address current barriers to biomarker testing in the community setting.

Due in no small part to global awareness efforts and transformative technological advances in breast cancer treatment, there has been a 40% decline in breast cancer deaths in the past 30 years. Nevertheless, current statistics remain sobering. An estimated 284,200 individuals in the U.S. will be diagnosed with invasive breast cancer in 2021, and approximately 44,130 people will die from the disease, making it the second leading cause of cancer death in women.

With projects that address acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), B-Cell ALL, and hematology disease education, ACCC is developing new resources for cancer programs and practices that focus on multidisciplinary approaches to caring for patients with blood cancer.

August 1 marks World Lung Cancer Day. Long at the forefront of teaching multidisciplinary cancer care teams about how to best implement new and evolving lung cancer therapies into their programs and practices, ACCC shares several of its current initiatives to promote optimal lung cancer care delivery.

May is Skin Cancer Awareness Month! Learn how the Cancer Support Community's patient guides help patient health literacy and promote shared decision-making.

Each May, Bladder Cancer Awareness Month helps highlight the facts about bladder cancer, promote awareness about the disease, and call for more investment in research, treatment, and care. This year’s theme emphasizes the importance promoting conversations about bladder cancer and its symptoms, treatments, and management.

To help address the ongoing prevalence of colorectal cancer, ACCC is inviting its members to submit proposals for quality improvement initiatives in treating metastatic forms of this cancer.

Growing knowledge of NSCLC subtypes and molecular biomarkers for this disease has led to changes in how NSCLC is diagnosed and staged.

I see the liver cancer heatmap being used as a source of networking between institutions and as a way to help patients find a medical facility to help navigate their care closer to home.